Rutin Suppresses DMBA Carcinogenesis in the Breast Through Modulating IL-6/NF-κB, SRC1/HSP90 and ER-α | Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds | Alps Pharmaceutical Ind. Co.,Ltd.

Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds

Rutin Suppresses DMBA Carcinogenesis in the Breast Through Modulating IL-6/NF-κB, SRC1/HSP90 and ER-α

Authors:: Seham S. M. Youssef; Nashwa K. Ibrahim; Sawsan M. El-Sonbaty; Magda K. El-Din Ezz

Reference:: Natural Product Communications; 2022; 17; 10.1177/1934578X221118213

DOI:: 10.1177/1934578X221118213

See Abstract

Key Words:: Rutin; rats; breast cancer; CA15-3; IL-6/NF-κB; SRC1/HSP90; animal experiments

Back to index